20 results on '"Lohse, Matthew B."'
Search Results
2. Variation in transcription regulator expression underlies differences in white–opaque switching between the SC5314 reference strain and the majority of Candida albicans clinical isolates.
- Author
-
Lohse, Matthew B., Ziv, Naomi, and Johnson, Alexander D.
- Subjects
- *
PROTEIN metabolism , *PROTEINS , *IN vitro studies , *FLOW cytometry , *FUNGI , *GENETIC variation , *ALLELES , *CELL communication , *GENE expression , *GENOMES , *RESEARCH funding , *GENE expression profiling , *CANDIDA albicans , *TRANSCRIPTION factors , *BIOLOGICAL assay , *POLYMERASE chain reaction , *PHENOTYPES - Abstract
Candida albicans, a normal member of the human microbiome and an opportunistic fungal pathogen, undergoes several morphological transitions. One of these transitions is white–opaque switching, where C. albicans alternates between 2 stable cell types with distinct cellular and colony morphologies, metabolic preferences, mating abilities, and interactions with the innate immune system. White-toopaque switching is regulated by mating type; it is repressed by the a1/α2 heterodimer in a/α cells, but this repression is lifted in a/a and α/α mating type cells (each of which are missing half of the repressor). The widely used C. albicans reference strain, SC5314, is unusual in that white–opaque switching is completely blocked when the cells are a/α; in contrast, most other C. albicans a/α strains can undergo white–opaque switching at an observable level. In this paper, we uncover the reason for this difference. We show that, in addition to repression by the a1/α2 heterodimer, SC5314 contains a second block to white–opaque switching: 4 transcription regulators of filamentous growth are upregulated in this strain and collectively suppress white–opaque switching. This second block is missing in the majority of clinical strains, and, although they still contain the a1/α2 heterodimer repressor, they exhibit a/α white–opaque switching at an observable level. When both blocks are absent, white–opaque switching occurs at very high levels. This work shows that white–opaque switching remains intact across a broad group of clinical strains, but the precise way it is regulated and therefore the frequency at which it occurs varies from strain to strain. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Structure of a new DNA-binding domain which regulates pathogenesis in a wide variety of fungi
- Author
-
Lohse, Matthew B., Rosenberg, Oren S., Cox, Jeffery S., Stroud, Robert M., Finer-Moore, Janet S., and Johnson, Alexander D.
- Published
- 2014
4. Identification and characterization of a previously undescribed family of sequence-specific DNA-binding domains
- Author
-
Lohse, Matthew B., Hernday, Aaron D., Fordyce, Polly M., Noiman, Liron, Sorrells, Trevor R., Hanson-Smith, Victor, Nobile, Clarissa J., DeRisi, Joseph L., and Johnson, Alexander D.
- Published
- 2013
5. Farnesol and phosphorylation of the transcriptional regulator Efg1 affect Candida albicans white-opaque switching rates.
- Author
-
Brenes, Lucas R., Johnson, Alexander D., and Lohse, Matthew B.
- Subjects
CANDIDA albicans ,PHOSPHORYLATION ,HUMAN microbiota ,CELL division - Abstract
Candida albicans is a normal member of the human microbiome and an opportunistic fungal pathogen. This species undergoes several morphological transitions, and here we consider white-opaque switching. In this switching program, C. albicans reversibly alternates between two cell types, named "white" and "opaque," each of which is normally stable across thousands of cell divisions. Although switching under most conditions is stochastic and rare, certain environmental signals or genetic manipulations can dramatically increase the rate of switching. Here, we report the identification of two new inputs which affect white-to-opaque switching rates. The first, exposure to sub-micromolar concentrations of (E,E)-farnesol, reduces white-to-opaque switching by ten-fold or more. The second input, an inferred PKA phosphorylation of residue T208 on the transcriptional regulator Efg1, increases white-to-opaque switching ten-fold. Combining these and other environmental inputs results in a variety of different switching rates, indicating that a given rate represents the integration of multiple inputs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Distinct class of DNA-binding domains is exemplified by a master regulator of phenotypic switching in Candida albicans
- Author
-
Lohse, Matthew B., Zordan, Rebecca E., Cain, Christopher W., Johnson, Alexander D., and Sauer, Robert T.
- Published
- 2010
7. Structure of the transcriptional network controlling white-opaque switching in Candida albicans
- Author
-
Hernday, Aaron D., Lohse, Matthew B., Fordyce, Polly M., Nobile, Clarissa J., DeRisi, Joseph L., and Johnson, Alexander D.
- Published
- 2013
- Full Text
- View/download PDF
8. Temporal anatomy of an epigenetic switch in cell programming: the white-opaque transition of C. albicans
- Author
-
Lohse, Matthew B and Johnson, Alexander D
- Published
- 2010
- Full Text
- View/download PDF
9. A Screen for Small Molecules to Target Candida albicans Biofilms.
- Author
-
Lohse, Matthew B., Ennis, Craig L., Hartooni, Nairi, Johnson, Alexander D., and Nobile, Clarissa J.
- Subjects
- *
CANDIDA albicans , *BIOFILMS , *ANTIFUNGAL agents , *DRUG resistance in microorganisms , *FLUCONAZOLE - Abstract
The human fungal pathogen Candida albicans can form biofilms on biotic and abiotic surfaces, which are inherently resistant to antifungal drugs. We screened the Chembridge Small Molecule Diversity library containing 30,000 “drug-like” small molecules and identified 45 compounds that inhibited biofilm formation. These 45 compounds were then tested for their abilities to disrupt mature biofilms and for combinatorial interactions with fluconazole, amphotericin B, and caspofungin, the three antifungal drugs most commonly prescribed to treat Candida infections. In the end, we identified one compound that moderately disrupted biofilm formation on its own and four compounds that moderately inhibited biofilm formation and/or moderately disrupted mature biofilms only in combination with either caspofungin or fluconazole. No combinatorial interactions were observed between the compounds and amphotericin B. As members of a diversity library, the identified compounds contain “drug-like” chemical backbones, thus even seemingly “weak hits” could represent promising chemical starting points for the development and the optimization of new classes of therapeutics designed to target Candida biofilms. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. An Opaque Cell-Specific Expression Program of Secreted Proteases and Transporters Allows Cell-Type Cooperation in Candida albicans.
- Author
-
Lohse, Matthew B., Brenes, Lucas R., Ziv, Naomi, Winter, Michael B., Craik, Charles S., and Johnson, Alexander D.
- Subjects
- *
CELL proliferation , *HUMAN microbiota , *CANDIDA albicans , *CARRIER proteins , *FLOW cytometry , *GENOMES , *LIQUID chromatography , *MASS spectrometry , *PROTEOLYTIC enzymes , *PROTEOMICS - Abstract
An unusual feature of the opportunistic pathogen Candida albicans is its ability to switch stochastically between two distinct, heritable cell types called white and opaque. Here, we show that only opaque cells, in response to environmental signals, massively upregulate a specific group of secreted proteases and peptide transporters, allowing exceptionally efficient use of proteins as sources of nitrogen. We identify the specific proteases [members of the secreted aspartyl protease (SAP) family] needed for opaque cells to proliferate under these conditions, and we identify four transcriptional regulators of this specialized proteolysis and uptake program. We also show that, in mixed cultures, opaque cells enable white cells to also proliferate efficiently when proteins are the sole nitrogen source. Based on these observations, we suggest that one role of white-opaque switching is to create mixed populations where the different phenotypes derived from a single genome are shared between two distinct cell types. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. A Set of Diverse Genes Influence the Frequency of White-Opaque Switching in Candida albicans.
- Author
-
Brenes, Lucas R., Lohse, Matthew B., Hartooni, Nairi, and Johnson, Alexander D.
- Subjects
- *
CANDIDA albicans , *GENE frequency , *GENETIC testing , *PROTEIN kinases , *HUMAN microbiota , *CANDIDEMIA , *OLFACTORY receptors - Abstract
The fungal species Candida albicans is both a member of the human microbiome and a fungal pathogen. C. albicans undergoes several different morphological transitions, including one called white-opaque switching. Here, cells reversibly switch between two states, "white" and "opaque," and each state is heritable through many cell generations. Each cell type has a distinct cellular and colony morphology and they differ in many other properties including mating, nutritional specialization, and interactions with the innate immune system. Previous genetic screens to gain insight into white-opaque switching have focused on certain classes of genes (for example transcriptional regulators or chromatin modifying enzymes). In this paper, we examined 172 deletion mutants covering a broad range of cell functions. We identified 28 deletion mutants with at least a fivefold effect on switching frequencies; these cover a wide variety of functions ranging from membrane sensors to kinases to proteins of unknown function. In agreement with previous reports, we found that components of the pheromone signaling cascade affect white-to-opaque switching; however, our results suggest that the major effect of Cek1 on white-opaque switching occurs through the cell wall damage response pathway. Most of the genes we identified have not been previously implicated in white-opaque switching and serve as entry points to understand new aspects of this morphological transition. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Combination of Antifungal Drugs and Protease Inhibitors Prevent Candida albicans Biofilm Formation and Disrupt Mature Biofilms.
- Author
-
Lohse, Matthew B., Gulati, Megha, Craik, Charles S., Johnson, Alexander D., and Nobile, Clarissa J.
- Subjects
ANTIFUNGAL agents ,PROTEASE inhibitors ,CANDIDA albicans ,BIOFILMS ,CANDIDIASIS ,AMPHOTERICIN B - Abstract
Biofilms formed by the fungal pathogen Candida albicans are resistant to many of the antifungal agents commonly used in the clinic. Previous reports suggest that protease inhibitors, specifically inhibitors of aspartyl proteases, could be effective antibiofilm agents. We screened three protease inhibitor libraries, containing a total of 80 compounds for the abilities to prevent C. albicans biofilm formation and to disrupt mature biofilms. The compounds were screened individually and in the presence of subinhibitory concentrations of the most commonly prescribed antifungal agents for Candida infections: fluconazole, amphotericin B, or caspofungin. Although few of the compounds affected biofilms on their own, seven aspartyl protease inhibitors inhibited biofilm formation when combined with amphotericin B or caspofungin. Furthermore, nine aspartyl protease inhibitors disrupted mature biofilms when combined with caspofungin. These results suggest that the combination of standard antifungal agents together with specific protease inhibitors may be useful in the prevention and treatment of C. albicans biofilm infections. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Candida albicans white and opaque cells exhibit distinct spectra of organ colonization in mouse models of infection.
- Author
-
Takagi, Julie, Singh-Babak, Sheena D., Lohse, Matthew B., Dalal, Chiraj K., and Johnson, Alexander D.
- Subjects
LEUCOCYTES ,CANDIDA albicans ,GASTROINTESTINAL system ,COLONIZATION ,MICE ,INTERLEUKIN-22 - Abstract
Candida albicans, a species of fungi, can thrive in diverse niches of its mammalian hosts; it is a normal resident of the GI tract and mucosal surfaces but it can also enter the bloodstream and colonize internal organs causing serious disease. The ability of C. albicans to thrive in these different host environments has been attributed, at least in part, to its ability to assume different morphological forms. In this work, we examine one such morphological change known as white-opaque switching. White cells are the default state of C. albicans, and most animal studies have been carried out exclusively with white cells. Here, we compared the proliferation of white and opaque cells in two murine models of infection and also monitored, using specially constructed strains, switching between the two states in the host. We found that white cells outcompeted opaque cells in many niches; however, we show for the first time that in some organs (specifically, the heart and spleen), opaque cells competed favorably with white cells and, when injected on their own, could colonize these organs. In environments where the introduced white cells outcompeted the introduced opaque cells, we observed high rates of opaque-to-white switching. We did not observe white-to-opaque switching in any of the niches we examined. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
14. Systematic Genetic Screen for Transcriptional Regulators of the Candida albicans White-Opaque Switch.
- Author
-
Lohse, Matthew B., Ene, Iuliana V., Craik, Veronica B., Hernday, Aaron D., Mancera, Eugenio, Morschhäuser, Joachim, Bennett, Richard J., and Johnson, Alexander D.
- Subjects
- *
CANDIDA albicans genetics , *FUNGAL genetics , *GENETIC regulation , *GENE expression , *MAMMAL genetics - Abstract
The human fungal pathogen Candida albicans can reversibly switch between two cell types named "white" and "opaque," each of which is stable through many cell divisions. These two cell types differ in their ability to mate, their metabolic preferences and their interactions with the mammalian innate immune system. A highly interconnected network of eight transcriptional regulators has been shown to control switching between these two cell types. To identify additional regulators of the switch, we systematically and quantitatively measured white-opaque switching rates of 196 strains, each deleted for a specific transcriptional regulator. We identified 19 new regulators with at least a 10-fold effect on switching rates and an additional 14 new regulators with more subtle effects. To investigate how these regulators affect switching rates, we examined several criteria, including the binding of the eight known regulators of switching to the control region of each new regulatory gene, differential expression of the newly found genes between cell types, and the growth rate of each mutant strain. This study highlights the complexity of the transcriptional network that regulates the white-opaque switch and the extent to which switching is linked to a variety of metabolic processes, including respiration and carbon utilization. In addition to revealing specific insights, the information reported here provides a foundation to understand the highly complex coupling of white-opaque switching to cellular physiology. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
15. Identification and Characterization of Wor4, a New Transcriptional Regulator of White-Opaque Switching.
- Author
-
Lohse, Matthew B. and Johnson, Alexander D.
- Subjects
- *
CANDIDA albicans , *CELL division , *DNA-binding proteins - Abstract
The human fungal pathogen Candida albicans can switch between two cell types, "white" and "opaque," each of which is heritable through many cell divisions. Switching between these two cell types is regulated by six transcriptional regulators that form a highly interconnected circuit with multiple feedback loops. Here, we identify a seventh regulator of white-opaque switching, which we have named Wor4. We show that ectopic expression of Wor4 is sufficient to drive switching from the white to the opaque cell type, and that deletion of Wor4 blocks switching from the white to the opaque cell type. A combination of ectopic expression and deletion experiments indicates that Wor4 is positioned upstream of Wor1, and that it is formally an activator of the opaque cell type. The combination of ectopic expression and deletion phenotypes for Wor4 is unique; none of the other six white-opaque regulators show this pattern. We determined the pattern of Wor4 binding across the genome by ChIP-seq and found it is highly correlated with that of Wor1 and Wor2, indicating that Wor4 is tightly integrated into the existing white-opaque regulatory circuit. We previously proposed that white-to-opaque switching relies on the activation of a complex circuit of feedback loops that remains excited through many cell divisions. The identification of a new, central regulator of white-opaque switching supports this idea by indicating that the white-opaque switching mechanism is considerably more complex than those controlling conventional, nonheritable patterns of gene expression. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. A Conserved Transcriptional Regulator Governs Fungal Morphology in Widely Diverged Species.
- Author
-
Cain, Christopher W., Lohse, Matthew B., Homann, Oliver R., Sil, Anita, and Johnson, Alexander D.
- Subjects
- *
ANIMAL morphology , *SACCHAROMYCES cerevisiae , *CANDIDA albicans , *CHROMATIN , *NUCLEOTIDE sequence - Abstract
Fungi exhibit a large variety of morphological forms. Here, we examine the functions of a deeply conserved regulator of morphology in three fungal species: Saccharomyces cerevisiae, Candida albicans, and Histoplasma capsulatum. We show that, despite an estimated 600 million years since those species diverged from a common ancestor, Wor1 in C. albicans, Ryp1 in H. capsulatum, and Mit1 in S. cerevisiae are transcriptional regulators that recognize the same DNA sequence. Previous work established that Wor1 regulates white-opaque switching in C. albicans and that its ortholog Ryp1 regulates the yeast to mycelial transition in H. capsulatum. Here we show that the ortholog Mit1 in S. cerevisiae is also a master regulator of a morphological transition, in this case pseudohyphal growth. Full-genome chromatin immunoprecipitation experiments show that Mit1 binds to the control regions of the previously known regulators of pseudohyphal growth as well as those of many additional genes. Through a comparison of binding sites for Mit1 in S. cerevisiae, Wor1 in C. albicans, and Wor1 ectopically expressed in S. cerevisiae, we conclude that the genes controlled by the orthologous regulators overlap only slightly between these two species despite the fact that the DNA binding specificity of the regulators has remained largely unchanged. We suggest that the ancestral Wor1/Mit1/Ryp1 protein controlled aspects of cell morphology and that movement of genes in and out of the Wor1/Mit1/Ryp1 regulon is responsible, in part, for the differences of morphological forms among these species. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
17. White–opaque switching in Candida albicans
- Author
-
Lohse, Matthew B and Johnson, Alexander D
- Subjects
- *
CANDIDA albicans , *YEAST , *EPIGENESIS , *BIOFILMS , *IMMUNE system , *MICROBIAL aggregation , *EDIBLE fungi - Abstract
The human commensal yeast Candida albicans undergoes an epigenetic switch between two distinct types of cells, referred to as white and opaque. These two cell types differ in many respects, including their cell and colony morphologies, their metabolic states, their mating behaviors, their preferred niches in the host, and their interactions with the host immune system. Each of the two cell types is heritable for many generations and switching between them appears stochastic; however, environmental cues can significantly alter the frequency of switching. We review recent work on white–opaque switching, including the establishment of the transcriptional circuit underlying this switch, the identification of environmental signals that affect switching rates, newly discovered differences between the two types of cells, and the involvement of white–opaque switching in biofilm formation. We also review recent speculation on the evolution and adaptive value of white–opaque switching. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
18. Differential Phagocytosis of White versus Opaque Candida albicans by Drosophila and Mouse Phagocytes.
- Author
-
Lohse, Matthew B. and Johnson, Alexander D.
- Subjects
- *
PHYSIOLOGY , *BIOLOGY , *PHAGOCYTES , *PHAGOCYTOSIS , *IMMUNE response , *IMMUNOLOGY , *CANDIDA albicans , *DROSOPHILA , *INTRODUCED insects - Abstract
The human fungal pathogen Candida albicans resides asymptomatically in the gut of most healthy people but causes serious invasive diseases in immunocompromised patients. Many C. albicans strains have the ability to stochastically switch between distinct white and opaque cell types, but it is not known with certainty what role this switching plays in the physiology of the organism. Here, we report a previously undescribed difference between white and opaque cells, namely their interaction with host phagocytic cells. We show that both Drosophila hemocyte-derived S2 cells and mouse macrophage-derived RAW264.7 cells preferentially phagocytose white cells over opaque cells. This difference is seen both in the overall percentage of cultured cells that phagocytose white versus opaque C. albicans and in the average number of C. albicans taken up by each phagocytic cell. We conclude that susceptibility to phagocytosis by cells of the innate immune system is an important distinction between white and opaque C. albicans, and propose that one role of switching from the prevalent white form into the rarer opaque form may be to allow C. albicans to escape phagocytosis. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
19. A Selective Serotonin Reuptake Inhibitor, a Proton Pump Inhibitor, and Two Calcium Channel Blockers Inhibit Candida albicans Biofilms.
- Author
-
Nobile, Clarissa J., Ennis, Craig L., Hartooni, Nairi, Johnson, Alexander D., and Lohse, Matthew B.
- Subjects
ANTIFUNGAL agents ,SEROTONIN uptake inhibitors ,CALCIUM antagonists ,PROTON pump inhibitors ,CANDIDA albicans ,BIOFILMS - Abstract
Biofilms formed by the human fungal pathogen Candida albicans are naturally resistant to many of the antifungal agents commonly used in the clinic. We screened a library containing 1600 clinically tested drug compounds to identify compounds that inhibit C. albicans biofilm formation. The compounds that emerged from the initial screen were validated in a secondary screen and then tested for (1) their abilities to disrupt mature biofilms and (2) for synergistic interactions with representatives of the three antifungal agents most commonly prescribed to treat Candida infections, fluconazole, amphotericin B, and caspofungin. Twenty compounds had antibiofilm activity in at least one of the secondary assays and several affected biofilms but, at the same concentration, had little or no effect on planktonic (suspension) growth of C. albicans. Two calcium channel blockers, a selective serotonin reuptake inhibitor, and an azole-based proton pump inhibitor were among the hits, suggesting that members of these three classes of drugs or their derivatives may be useful for treating C. albicans biofilm infections. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. Regulation of the GTPase Cycle in Post-translational Signal Recognition Particle-based Protein Targeting Involves cpSRP43.
- Author
-
Goforth, Robyn L., Peterson, Eric C., Jianguo Yuan, Moore, Misty J., Kight, Alicia D., Lohse, Matthew B., Sakon, Joshua, and Henry, Ralph L.
- Subjects
- *
CARRIER proteins , *HOMOLOGY (Biology) , *PROTEINS , *CHLOROPLASTS , *GUANOSINE triphosphatase , *BIOCHEMISTRY - Abstract
The chloroplast signal recognition particle consists of a conserved 54-kDa GTPase and a novel 43-kDa chromodomain protein (cpSRP43) that together bind light-harvesting chlorophyll a/b-binding protein (LHCP) to form a soluble targeting complex that is subsequently directed to the thylakoid membrane. Homology-based modeling of cpSRP43 indicates the presence of two previously identified chromodomains along with a third N-terminal chromodomain. Chromodomain deletion constructs were used to examine the role of each chromodomain in mediating distinct steps in the LHCP localization mechanism. The C-terminal chromodomain is completely dispensable for LHCP targeting/integration in vitro. The central chromodomain is essential for both targeting complex formation and integration because of its role in binding the M domain of cpSRP54. The Nterminal chromodomain (CD1) is unnecessary for targeting complex formation but is required for integration. This correlates with the ability of CD1 along with the ankyrin repeat region of cpSRP43 to regulate the GTPase cycle of the cpSRP-receptor complex. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.